• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过趋化因子受体 CXCR4 和 CXCR7 进行肿瘤近红外分子成像。

Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7.

机构信息

Department of Anatomy, University of Kiel, Olshausenstraße 40, 24098 Kiel, Germany.

出版信息

Clin Exp Metastasis. 2011 Dec;28(8):713-20. doi: 10.1007/s10585-011-9403-y. Epub 2011 Jul 7.

DOI:10.1007/s10585-011-9403-y
PMID:21735100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3213350/
Abstract

The chemokine CXCL12/SDF-1 and its receptors CXCR4 and CXCR7 play a major role in tumor invasion, proliferation and metastasis. Since both receptors are overexpressed on distinct tumor cells and on the tumor vasculature, we evaluated their potential as targets for detection of cancers by molecular imaging. We synthesized conjugates of CXCL12 and the near-infrared (NIR) fluorescent dye IRDye(®)800CW, tested their selectivity, sensitivity and biological activity in vitro and their feasibility to visualize tumors in vivo. Purified CXCL12-conjugates detected in vitro as low as 500 A764 human glioma cells or MCF-7 breast cancer cells that express CXCR7 alone or together with CXCR4. Binding was time- and concentration-dependent, and the label could be competitively displaced by the native peptide. Control conjugates with bovine serum albumin or lactalbumin failed to label the cells. In mice, the conjugate distributed rapidly. After 1-92 h, subcutaneous tumors of human MCF-7 and A764 cells in immunodeficient mice were detected with high sensitivity. Background was observed in particular in liver within the first 24 h, but also skull and hind limbs yielded some background. Overall, fluorescent CXCL12-conjugates are sensitive and selective probes to detect solid and metastatic tumors by targeting tumor cells and tumor vasculature.

摘要

趋化因子 CXCL12/SDF-1 及其受体 CXCR4 和 CXCR7 在肿瘤侵袭、增殖和转移中发挥重要作用。由于这两种受体在不同的肿瘤细胞和肿瘤血管上过度表达,我们评估了它们作为通过分子成像检测癌症的潜在靶点的能力。我们合成了 CXCL12 与近红外(NIR)荧光染料 IRDye(®)800CW 的缀合物,测试了它们在体外的选择性、灵敏度和生物活性,以及在体内可视化肿瘤的可行性。体外纯化的 CXCL12 缀合物可检测到低至 500 个 A764 人神经胶质瘤细胞或单独表达 CXCR7 或与 CXCR4 一起表达的 MCF-7 乳腺癌细胞。结合是时间和浓度依赖性的,并且可以通过天然肽进行竞争性置换。带有牛血清白蛋白或乳白蛋白的对照缀合物未能标记细胞。在小鼠中,缀合物分布迅速。在免疫缺陷小鼠中,1-92 小时后,可高度敏感地检测到皮下的 MCF-7 和 A764 细胞肿瘤。在最初的 24 小时内,特别是在肝脏中观察到背景,但颅骨和后肢也产生了一些背景。总的来说,荧光 CXCL12 缀合物是敏感和选择性的探针,可通过靶向肿瘤细胞和肿瘤血管来检测实体瘤和转移性肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/6026d62b40f4/10585_2011_9403_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/2995c297a467/10585_2011_9403_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/2fa6a840d13d/10585_2011_9403_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/193718da754b/10585_2011_9403_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/6026d62b40f4/10585_2011_9403_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/2995c297a467/10585_2011_9403_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/2fa6a840d13d/10585_2011_9403_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/193718da754b/10585_2011_9403_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/3213350/6026d62b40f4/10585_2011_9403_Fig4_HTML.jpg

相似文献

1
Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7.通过趋化因子受体 CXCR4 和 CXCR7 进行肿瘤近红外分子成像。
Clin Exp Metastasis. 2011 Dec;28(8):713-20. doi: 10.1007/s10585-011-9403-y. Epub 2011 Jul 7.
2
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.趋化因子 CXCL12 被 CXCR7 清除可促进 CXCR4 阳性乳腺癌细胞的肿瘤生长和转移。
Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.
3
Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.趋化因子受体 4 和 7 在乳腺癌转移中的相反作用。
Breast Cancer Res. 2011;13(6):R128. doi: 10.1186/bcr3074. Epub 2011 Dec 9.
4
Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.雌激素对趋化因子受体 CXCL12 的差异调节,CXCR4 和 CXCR7,有助于雌激素对乳腺癌细胞的生长作用。
PLoS One. 2011;6(6):e20898. doi: 10.1371/journal.pone.0020898. Epub 2011 Jun 10.
5
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.趋化因子CXCL12及其受体CXCR4和CXCR7在人MCF-7乳腺癌细胞中的联合内化作用。
Cell Tissue Res. 2014 Jul;357(1):253-66. doi: 10.1007/s00441-014-1823-y. Epub 2014 Apr 26.
6
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.CXCL12、CXCR4和CXCR7在乳腺癌患者中的预后意义。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13217-24. eCollection 2015.
7
CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.CXCR7 并非人卵巢癌细胞上皮间质转化所必需的 CXCL12-CXCR4 诱导因素。
Mol Carcinog. 2019 Jan;58(1):144-155. doi: 10.1002/mc.22916. Epub 2018 Oct 16.
8
Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.用于CXCR4和CXCR7细胞研究的生物发光CXCL12融合蛋白。
Biotechniques. 2009 Jul;47(1):625-32. doi: 10.2144/000113126.
9
Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.CXCL12/CXCR4/CXCR7 轴在膀胱癌发病机制中的生物学/病理学功能。
Int J Clin Oncol. 2017 Dec;22(6):991-1000. doi: 10.1007/s10147-017-1187-x. Epub 2017 Oct 11.
10
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.CXCL12-CXCR4/CXCR7 轴在结直肠癌中的作用:临床前和临床研究中的治疗靶点。
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.

引用本文的文献

1
Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents.通过使用术中荧光成像剂优化胶质母细胞瘤手术
Pharmaceuticals (Basel). 2022 Apr 29;15(5):550. doi: 10.3390/ph15050550.
2
Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.荧光分子靶向结肠癌,使隐匿病灶可视化。
Cells. 2022 Jan 12;11(2):249. doi: 10.3390/cells11020249.
3
Investigating CXCR4 expression of tumor cells and the vascular compartment: A multimodal approach.研究肿瘤细胞和血管区室的 CXCR4 表达:一种多模态方法。

本文引用的文献

1
Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.组成型和趋化因子依赖性内化和乳腺癌细胞中 CXCR7 的再循环,以降解趋化因子配体。
Oncogene. 2010 Aug 12;29(32):4599-610. doi: 10.1038/onc.2010.212. Epub 2010 Jun 7.
2
Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.采用[64Cu]AMD3100 正电子发射断层扫描术对人源异种移植瘤中 CXCR4 受体表达的分子成像。
Cancer Res. 2010 May 15;70(10):3935-44. doi: 10.1158/0008-5472.CAN-09-4396. Epub 2010 May 11.
3
The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
PLoS One. 2021 Nov 18;16(11):e0260186. doi: 10.1371/journal.pone.0260186. eCollection 2021.
4
The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma.CXCL12/CXCR4轴在食管鳞状细胞癌中的生物学作用。
Cancer Biol Med. 2021 Mar 12;18(2):401-10. doi: 10.20892/j.issn.2095-3941.2020.0140.
5
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.一种新型 CXCR4 靶向近红外(NIR)荧光探针(肽 R-NIR750)特异性检测 CXCR4 表达的肿瘤。
Sci Rep. 2017 May 31;7(1):2554. doi: 10.1038/s41598-017-02818-6.
6
Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.在乳腺癌细胞腹侧通过生物材料递送基质细胞衍生因子-1α揭示了细胞受体之间的相互作用以促进侵袭性表型。
Biomaterials. 2017 May;127:61-74. doi: 10.1016/j.biomaterials.2017.02.035. Epub 2017 Feb 27.
7
Intraoperative Fluorescence Imaging for Personalized Brain Tumor Resection: Current State and Future Directions.术中荧光成像用于个性化脑肿瘤切除术:现状与未来方向
Front Surg. 2016 Oct 17;3:55. doi: 10.3389/fsurg.2016.00055. eCollection 2016.
8
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.人癌异种移植模型中非典型趋化因子受体3(ACKR3/CXCR7)的靶向成像
J Nucl Med. 2016 Jun;57(6):981-8. doi: 10.2967/jnumed.115.167932. Epub 2016 Feb 23.
9
CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer.CXCL12-CXCR4轴促进卵巢癌的增殖、迁移、侵袭和转移。
Oncol Res. 2014;22(5-6):247-58. doi: 10.3727/096504015X14343704124430.
10
CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model.靶向CXCR4的近红外成像可在小鼠模型中检测原位和转移性人骨肉瘤。
Sci Rep. 2015 Oct 16;5:15244. doi: 10.1038/srep15244.
趋化因子受体 CXCR7 在人神经胶质瘤细胞中高表达,并介导抗细胞凋亡作用。
Cancer Res. 2010 Apr 15;70(8):3299-308. doi: 10.1158/0008-5472.CAN-09-3642. Epub 2010 Apr 13.
4
Molecular imaging targeting peptide receptors.靶向肽受体的分子成像
Methods. 2009 Jun;48(2):161-77. doi: 10.1016/j.ymeth.2009.03.012. Epub 2009 Mar 24.
5
In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.使用单克隆抗体与吲哚菁绿的缀合物,通过淬灭型近红外荧光探针进行癌症的体内分子成像。
Cancer Res. 2009 Feb 15;69(4):1268-72. doi: 10.1158/0008-5472.CAN-08-3116. Epub 2009 Jan 27.
6
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.CXCR4拮抗剂:靶向白血病及其他癌症中的微环境
Leukemia. 2009 Jan;23(1):43-52. doi: 10.1038/leu.2008.299. Epub 2008 Nov 6.
7
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models.用于小鼠癌症模型的近红外2-脱氧葡萄糖光学成像剂的表征与性能
Anal Biochem. 2009 Jan 15;384(2):254-62. doi: 10.1016/j.ab.2008.09.050. Epub 2008 Oct 7.
8
The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6.趋化因子CXCL16通过其受体CXCR6诱导神经胶质前体细胞的迁移和侵袭。
Mol Cell Neurosci. 2008 Sep;39(1):133-41. doi: 10.1016/j.mcn.2008.03.009. Epub 2008 Apr 10.
9
The role of CXC chemokines and their receptors in cancer.CXC趋化因子及其受体在癌症中的作用。
Cancer Lett. 2008 Aug 28;267(2):226-44. doi: 10.1016/j.canlet.2008.04.050. Epub 2008 Jun 24.
10
Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha.使用99mTc标记的SDF-1α对心肌梗死中CXCR4表达进行定量分析。
J Nucl Med. 2008 Jun;49(6):963-9. doi: 10.2967/jnumed.107.050054. Epub 2008 May 15.